SCHEMBL2790721

SCHEMBL2790721

Cc1c(C(=O)O)c(O)c2ccccc2c1Br

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 3/20 0.45
▸ LDHA P00338 3/20 0.42
▸ LDHB P07195 3/20 0.42
▸ TSHR P16473 2/20 0.41
▸ HMGB1 P09429 1/20 0.41
▸ CXCL12 P48061 1/20 0.41
▸ HPGD P15428 3/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ THRB P10828 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ ATIC P31939 1/20 0.41
▸ KMT2A Q03164 4/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ DHODH Q02127 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5162563 0.85 PDE10A (0.50) PDE10ALDHALDHBTSHRHMGB1
SCHEMBL29291851 0.81 HMGB1 (0.46) PDE10ALDHATSHRHMGB1CXCL12
SCHEMBL30706629 0.79 LDHA (0.49) PDE10ALDHALDHBTSHRHMGB1
SCHEMBL19203141 0.79 LDHA (0.49) PDE10ALDHALDHBTSHRHMGB1
SCHEMBL6171244 0.79 PDE10A (0.49) PDE10ALDHALDHBTSHRHMGB1
SCHEMBL2791364 0.79 KMT2A (0.46) PDE10ALDHALDHBTSHRHPGD
SCHEMBL4415520 0.78 HSD17B10 (0.54) PDE10ALDHATSHRHMGB1CXCL12
SCHEMBL31414101 0.78 HSD17B10 (0.54) PDE10ALDHATSHRHMGB1CXCL12
SCHEMBL28184860 0.77 PDE10A (0.47) PDE10ALDHALDHBTSHRHPGD
SCHEMBL4556957 0.77 HSD17B10 (0.45) PDE10ALDHATSHRHMGB1CXCL12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041657-A1 HALOALKYLSULFONE SUBSTITUTED COMPOUNDS USEFUL FOR TREATING OBESITY AND DIABETES NOVO NORDICK A/S (DK) 2010-02-18 — — US claimed
CN-101175720-A Novel haloalkyl sulfone substituted compounds useful for the treatment of obesity and diabetes NOVO NORDISK AS (DK) 2008-05-07 — — CN claimed
EP-3654395-B9 ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY SFC CO LTD (KR) 2024-11-06 — — EP disclosed
EP-3654395-B1 ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY SFC CO LTD (KR) 2024-08-28 — — EP disclosed
CN-116528647-A Novel amine compound and organic light-emitting element comprising same SFC株式会社 2023-08-01 — — CN disclosed
US-11563181-B2 Amine compounds for organic light-emitting diode and organic light-emitting diode including the same SFC CO., LTD. (KR) 2023-01-24 — — US disclosed
US-11532792-B2 Organic light emitting diode having high efficiency SFC CO., LTD. (KR) 2022-12-20 — — US disclosed
EP-3654395-A1 ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY SFC Co., Ltd. (KR) 2020-05-20 — — EP disclosed
US-20200127209-A1 ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY SFC CO., LTD. (KR) 2020-04-23 — — US disclosed
US-20170141322-A1 NOVEL AMINE COMPOUNDS FOR ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME SFC CO., LTD. (KR) 2017-05-18 — — US disclosed
US-20100041657-A1 HALOALKYLSULFONE SUBSTITUTED COMPOUNDS USEFUL FOR TREATING OBESITY AND DIABETES NOVO NORDICK A/S (DK) 2010-02-18 — — US disclosed
CN-101175720-A Novel haloalkyl sulfone substituted compounds useful for the treatment of obesity and diabetes NOVO NORDISK AS (DK) 2008-05-07 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141322-A1 NOVEL AMINE COMPOUNDS FOR ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME DRD1, DRD4, DRD2 PDE10A 3880/4885LDHA 975/4885LDHB 1030/4885
US-11563181-B2 Amine compounds for organic light-emitting diode and organic light-emitting diode including the same DRD1, DRD4, DRD2 PDE10A 4116/4885LDHA 869/4885LDHB 933/4885
US-11532792-B2 Organic light emitting diode having high efficiency CYBA, SLC1A2, MAOB PDE10A 3210/4885LDHA 237/4885LDHB 128/4885
US-20100041657-A1 HALOALKYLSULFONE SUBSTITUTED COMPOUNDS USEFUL FOR TREATING OBESITY AND DIABETES RPS12, GPR119, ATP12A PDE10A 3565/4885LDHA 4357/4885LDHB 4241/4885
US-20200127209-A1 ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY CYBA, SLC1A2, MAOB PDE10A 3210/4885LDHA 237/4885LDHB 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback